Kenya launches long-acting HIV prevention drug Lenacapavir

Kenya has launched Lenacapavir, a new long-acting injectable drug for HIV prevention, marking a significant advancement in managing the epidemic.

Kenya welcomes Lenacapavir, six-month HIV prevention injection

Kenya launches long-acting injectable HIV prevention medicine in phased rollout

Kenya begins nationwide rollout of long-acting HIV prevention drug

Kenya has officially launched the nationwide rollout of Lenacapavir (LEN), a new long-acting injectable drug for HIV prevention, on Thursday, February 27, 2026. This significant advancement offers a more convenient option alongside existing oral and injectable PrEP methods.

New HIV prevention injection arrives in Kenya

A new HIV prevention injection, Lenacapavir, has arrived in Kenya, offering a potentially "game-changing" treatment that requires only two injections a year.